首页EKSO • NASDAQ
add
Ekso Bionics
昨日收盘价
$0.72
当日价格范围
$0.67 - $0.74
年度波幅
$0.67 - $3.13
市值
1520.09万 USD
平均交易量
9.01万
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 412.90万 | -10.38% |
经营支出 | 484.80万 | -10.01% |
净收入 | -207.20万 | 38.42% |
净利润率 | -50.18 | 31.30% |
每股收益 | — | — |
息税折旧摊销前利润 | -223.20万 | 10.97% |
有效税率 | — | — |
资产负债表
总资产
负债总额
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 829.20万 | -16.55% |
总资产 | 2920.90万 | -6.33% |
负债总额 | 1433.90万 | -9.96% |
权益总额 | 1487.00万 | — |
发行在外的股份 | 2199.84万 | — |
市净率 | 1.06 | — |
资产回报率 | -23.48% | — |
资本回报率 | -33.02% | — |
现金流
现金净变动
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | -207.20万 | 38.42% |
来自运营的现金 | -227.70万 | 32.09% |
投资现金 | -8000.00 | 52.94% |
融资现金 | 469.10万 | — |
现金净变动 | 240.70万 | 171.42% |
自由现金流 | -111.28万 | 57.80% |
简介
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
CEO
成立时间
2005
员工数量
70